News Quantified

CPRX – catalyst pharmaceuticals, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Catalyst Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Santhera Receives Positive Recommendation from NICE for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy [Yahoo! Finance]

Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock's On An Uptrend: Are Strong Financials Guiding The Market? [Yahoo! Finance]

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick [Yahoo! Finance]

Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term [Yahoo! Finance]

2.1%

BEAT

7.6%

BEAT

3.6%

BEAT

8.8%

MISS

Form 4 CATALYST PHARMACEUTICALS For: Dec 13 Filed by: Miller Steve

Form 4 CATALYST PHARMACEUTICALS For: Dec 09 Filed by: Elsbernd Brian

Form 4 CATALYST PHARMACEUTICALS For: Dec 09 Filed by: INGENITO GARY

Form 4 CATALYST PHARMACEUTICALS For: Dec 09 Filed by: Thompson Tamar

Form 4 CATALYST PHARMACEUTICALS For: Dec 09 Filed by: Tierney David S

Top News Gainers

5/9 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. 15.9%

5/14 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was given a new $9.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock. 12.7%

4/8 Catalyst Pharmaceuticals Provides Update on Impact of COVID-19 Pandemic on its Business Activities 11.5%

1/6 Catalyst Pharmaceuticals Pre-Announces Estimated Firdapse® Revenues and Provides Updates on Advancement of Clinical Development Programs 11.1%

3/10 Catalyst Pharmaceuticals to Hold Fourth Quarter and Year-End Financial Results and Corporate Update Conference Call and Webcast on Tuesday, March 17th, 2020 9.8%

2/5 Form 8-K CATALYST PHARMACEUTICALS For: Feb 04 9.5%

3/16 Q4/2019 12/31/2019 EPS 0.070 ZacksConsensus 0.090 ActVsEst (0.020) - Miss 8.6%

6/12 Catalyst Pharmaceuticals Files Federal Lawsuit Against U.S. Food and Drug Administration 7.9%

11/13 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) had its price target lowered by analysts at Piper Jaffray Companies from $8.00 to $7.00. 5.6%

9/24 Form 8-K CATALYST PHARMACEUTICALS For: Sep 23 5.5%

Top News Decliners

3/15 Catalyst Pharmaceuticals Q4 2019 Earnings Preview [Seeking Alpha] -23.2%

9/11 Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock -14.9%

10/30 Catalyst Pharmaceuticals Announces Top-Line Results of CMS-001, a Phase 3 Trial of Firdapse® (Amifampridine Phosphate) in Patients with Congenital Myasthenic Syndromes (CMS) -14.5%

4/14 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -12.1%

5/13 Form 8-K CATALYST PHARMACEUTICALS For: May 13 -11.7%

8/7 Q2/2019 6/30/2019 EPS 0.100 ZacksConsensus 0.030 ActVsEst 0.070 - Beat -10.7%

2/27 Catalyst Pharmaceuticals Announces Support of Rare Disease Day 2020 -10.3%

12/20 Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -8.9%

9/13 Form 8-K CATALYST PHARMACEUTICALS For: Sep 13 -8.0%

11/12 Form 10-Q CATALYST PHARMACEUTICALS For: Sep 30 -7.3%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day